AbbVie Commits $35 Million for COVID-19 Relief Efforts in U.S., Europe

AbbVie Commits $35 Million for COVID-19 Relief Efforts in U.S., Europe

Global pharmaceuticals company AbbVie has announced contributions totaling $35 million in support of COVID-19 relief efforts in the United States and Europe.

The commitment includes funding to help the International Medical Corps procure tents, equipment, and supplies for the twenty mobile field hospitals it is in the process of deploying across the United States. To date, IMC has launched field hospitals in Boston, Chicago, Cleveland, Detroit, Los Angeles, New Orleans, New York City, and Puerto Rico.

The company also is supporting the efforts of humanitarian organization Direct Relief to deliver equipment and supplies to the hardest-hit areas of Europe, including personal protective equipment (PPE) for frontline healthcare workers and oxygen concentrators and ventilators for patients, and is making a donation to Feeding America's COVID-19 Response Fund.

In addition, the company designated $5 million in reserve funding for future needs, has created a Community Resilience Fund to provide funding to organizations working to build resilience in underresourced communities impacted by COVID, and is providing support through the AbbVie Employee Assistance Fund's Employee Relief Program to help cover mortgage/rent payments, utility bills, food costs, childcare, and medical expenses for employees impacted by the virus and will double the match it provides through the AbbVie Foundation for COVID-19-related donations made by employees.

"AbbVie is making this donation to nonprofit partners that will have an immediate and significant positive impact in communities that have been hit hardest by this unprecedented crisis," said AbbVie chair and CEO Richard A. Gonzalez. "Our thirty thousand AbbVie team members around the world are proud to be able to help make a difference in the fight against this virus."

(Photo credit: International Medical Corps)